Johnson & Johnson subsidiary, Ethicon, Inc., produced a medical device known as "Gynecare Intergel Adhesion Prevention Solution," which was approved for use by the FDA in November of 2001. By April of 2003, the FDA introduced a voluntary market withdrawal, urging people to immediately stop using the device.
This was a thick gel used by surgeons to coat the inner lining of the abdominal cavity to prevent scar tissue from forming after gynecological surgery. However, in many women, the gel caused the exact opposite to occur, creating severe post-surgery complications.
Kershaw, Cutter & Ratinoff's expert medical device recall attorneys successfully represented 60 women who alleged they were injured following the use of Gynecare Intergel. Facing off against the large and resourceful Johnson & Johnson, KCR injury attorneys successfully obtained a sizable, yet court-ordered confidential, settlement on behalf of the injured women.